No data to show
XNYS
STVN
Market cap5.98bUSD
Apr 11, Last price
21.91USD
1D
6.20%
1Q
-4.49%
IPO
12.13%
Name
Stevanato Group SpA
Chart & Performance
P/E
44.69
P/S
4.77
EPS
0.43
Div Yield, %
0.26%
Shrs. gr., 5y
0.61%
Rev. gr., 5y
15.53%
Revenues
1.10b
+1.72%
Net income
118m
-19.13%
CFO
156m
+48.06%
Dividend
Jun 04, 20240.058 USD/sh
Earnings
May 22, 2025
Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 1,104,036 1.72% | 1,085,354 10.33% | 983,700 16.57% | ||||
Cost of revenue | 951,985 | 897,594 | 810,100 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 152,051 | 187,760 | 173,600 | ||||
NOPBT Margin | 13.77% | 17.30% | 17.65% | ||||
Operating Taxes | 42,522 | 43,863 | 44,600 | ||||
Tax Rate | 27.97% | 23.36% | 25.69% | ||||
NOPAT | 109,529 | 143,897 | 129,000 | ||||
Net income | 117,778 -19.13% | 145,631 1.95% | 142,849 6.35% | ||||
Dividends | (14,457) | (14,294) | (13,257) | ||||
Dividend yield | 0.24% | 0.20% | 0.28% | ||||
Proceeds from repurchase of equity | 169,772 | ||||||
BB yield | -2.86% | ||||||
| Debt | |||||||
Debt current | 111,934 | 141,438 | 69,959 | ||||
Long-term debt | 333,937 | 274,096 | 168,389 | ||||
Deferred revenue | 44,046 | ||||||
Other long-term liabilities | 73,318 | 109,392 | (116,459) | ||||
Net debt | 341,960 | 342,102 | (20,126) | ||||
| Cash flow | |||||||
Cash from operating activities | 155,776 | 105,210 | 103,300 | ||||
CAPEX | (302,600) | (433,233) | (243,127) | ||||
Cash from investing activities | (310,214) | (421,223) | (243,000) | ||||
Cash from financing activities | 183,221 | 158,030 | (44,500) | ||||
FCF | (168,661) | (433,152) | (181,003) | ||||
| Balance | |||||||
Cash | 98,270 | 72,179 | 256,648 | ||||
Long term investments | 5,641 | 1,253 | 1,826 | ||||
Excess cash | 48,709 | 19,164 | 209,289 | ||||
Stockholders' equity | 871,968 | 770,567 | 879,061 | ||||
Invested Capital | 1,902,010 | 1,619,463 | 994,593 | ||||
ROIC | 6.22% | 11.01% | 15.43% | ||||
ROCE | 7.74% | 11.46% | 14.17% | ||||
| EV | |||||||
Common stock shares outstanding | 272,880 | 264,978 | 264,699 | ||||
Price | 21.79 -20.15% | 27.29 51.86% | 17.97 -19.96% | ||||
Market cap | 5,946,053 -17.77% | 7,231,237 52.02% | 4,756,650 -19.96% | ||||
EV | 6,288,059 | 7,573,454 | 4,736,304 | ||||
EBITDA | 232,703 | 266,240 | 238,423 | ||||
EV/EBITDA | 27.02 | 28.45 | 19.87 | ||||
Interest | 6,864 | 4,227 | 29,800 | ||||
Interest/NOPBT | 4.51% | 2.25% | 17.17% | ||||